The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

Me, the DNA-testing firm that filed for bankruptcy protection in March, is under investigation by the House Committee on Energy and Commerce over concerns related to the sale of its genetic data.